The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches
Open accessAbstract
Drug resistance remains a significant challenge in the treatment of colorectal cancer (CRC). In recent years, the emerging field of ferroptosis, a unique form of regulated cell death characterized by iron-dependent lipid peroxidation, has offered new insights and potential therapeutic strategies for overcoming drug resistance in CRC. This review examines the role of ferroptosis in CRC and its impact on drug resistance. It highlights the distinctive features and advantages of ferroptosis compared to other cell death pathways, such as apoptosis and necrosis. Furthermore, the review discusses current research advances in the field, including novel treatment approaches that target ferroptosis. These approaches involve the use of ferroptosis inducers, interventions in iron metabolism and lipid peroxidation, and combination therapies to enhance the efficacy of ferroptosis. The review also explores the potential of immunotherapy in modulating ferroptosis as a therapeutic strategy. Additionally, it evaluates the strengths and limitations of targeting ferroptosis, such as its selectivity, low side effects, and potential to overcome resistance, as well as challenges related to treatment specificity and drug development. Looking to the future, this review discusses the prospects of ferroptosis-based therapies in CRC, emphasizing the importance of further research to elucidate the interaction between ferroptosis and drug resistance. It proposes future directions for more effective treatment strategies, including the development of new therapeutic approaches, combination therapies, and integration with emerging fields such as precision medicine. In conclusion, harnessing ferroptosis represents a promising avenue for overcoming drug resistance in CRC. Continued research efforts in this field are crucial for optimizing therapeutic outcomes and providing hope for CRC patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, changes in drug metabolism contribute to resistance, with CRC cells increasing the inactivation or degradation of drugs through upregulated expression of enzymes like glutathione S-transferases (GSTs), uridine 5′-diphospho-glucuronosyltransferases (UGTs), and cytochrome P450 (CYP) enzymes [46,47].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [46]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Other ferroptosis-based strategies could involve interventions in iron metabolism and lipid peroxidation [46].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED ARTICLE: MiR-19a suppresses ferroptosis of colorectal cancer cells by targeting IREB2
Fan, H., Ai, R., Mu, S., Niu, X., Guo, Z., & Liu, L. (2022) · Bioengineered · doi:10.1080/21655979.2022.2054194 · Cited by 62
RetractedChen, Z., Zhu, Y., Dong, Y., Zhang, P., Han, X., Jin, J., & Ma, X. (2017) · Clinical Science · doi:10.1042/cs20171069 · Cited by 58
RetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
Ferroptosis: mechanisms, biology and role in disease
Jiang, X., Stockwell, B. R., & Conrad, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00324-8 · Cited by 7,505
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2239 · Cited by 4,293
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
Bersuker, K., Hendricks, J. M., Li, Z., Magtanong, L., Ford, B., Tang, P. H., Roberts, M. A., Tong, B., Maimone, T. J., Zoncu, R., et al. (2019) · Nature · doi:10.1038/s41586-019-1705-2 · Cited by 3,703
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw235 · Cited by 3,421
Cited by
Lipid metabolism in ferroptosis: mechanistic insights and therapeutic potential
Sun, D., Wang, L., Wu, Y., Yu, Y., Yao, Y., Yang, H., & Hao, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1545339 · Cited by 89
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82
“…in drug metabolism contribute to resistance, with CRC cells increasing the inactivation or degradation of drugs through upregulated expression of enzymes like glutathione S-transferases (GSTs), uridine 5 ′ -diphospho-glucuronosyltransferases (UGTs), and cytochrome P450 (CYP) enzymes [46,47].”
Non-coding RNA: A key regulator in the Glutathione-GPX4 pathway of ferroptosis
Hussain, M. S., Gupta, G., Shahwan, M. J., Bansal, P., Kaur, H., Deorari, M., Pant, K., Ali, H., Singh, S. K., Allam, V. S. R. R., et al. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.05.007 · Cited by 51
Ferroptosis and immunosenescence in colorectal cancer
Wang, Y., Cao, X., Yang, C., Fan, J., Zhang, X., Wu, X., Guo, W., Sun, S., Liu, M., Zhang, L., et al. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.10.003 · Cited by 52
Cell death signaling and immune regulation: new perspectives on targeted therapy for sepsis
Wu, H., Cui, J., Huang, J., Feng, Y., Zhao, J., Zhu, Y., Deng, X., Li, X., Zhang, W., & Wang, C. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00784-w · Cited by 34
Metadata
- Authors
- Cheng, X., Zhao, F., Ke, B., Chen, D., & Liu, F.
- Affiliations
- First Affiliated Hospital Zhejiang University (CN)
- Corresponding author
- Cheng, Xiaofei
- Liu, Fanlong
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2023-10-30
- Volume
- 15
- Issue
- 21
- Pages
- 5209
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC10649072
- OpenAlex
- W4388017931
- Cited by
- 44
- References
- 137
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 12
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- ferroptosis, colorectal cancer, drug resistance, iron metabolism, lipid peroxidation, ferroptosis inducers, combination therapy, immunotherapy, targeted therapy, precision medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches. https://app.cochat.ai/papers/10.3390/cancers15215209
- The paper
- Cheng, X., Zhao, F., Ke, B., Chen, D., & Liu, F. (2023). Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches. Cancers. https://doi.org/10.3390/cancers15215209
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.